2012-07-30T19:15:38-05:00 2011-09-30 ERNST & YOUNG US LLP 111 MONUMENT CIRCLE STE 2600 INDIANAPOLIS IN 46204 990 2010-10-01 043102433 Dana-Farber Inc DANA 6176323000 450 Brookline Ave BP418 Boston MA 02215 DOROTHY PUHY 2012-07-30 3176817000 2010 2016-02-24 21:20:13Z X Edward J Benz Jr MD 450 Brookline Boston MA 02215 518263676 false X N/A X 1990 MA The purpose & activities at Dana-Farber, Inc. are to promote & support the exempt missions of Dana-Farber Cancer Institute and to provide investment management services to support such purposes. 4 1 0 0 -82559 -97259 0 0 0 0 2244163 40236993 0 0 2244163 40236993 0 0 0 0 0 0 0 0 0 1337366 2915190 1337366 2915190 906797 37321803 545985276 571842417 545985276 571842417 0 THE PURPOSE & ACTIVITIES AT DANA-FARBER, INC. ARE TO PROMOTE & SUPPORT THE EXEMPT MISSIONS OF DANA-FARBER CANCER INSTITUTE AND TO PROVIDE INVESTMENT MANAGEMENT SERVICES TO SUPPORT SUCH PURPOSES. false false 0 0 0 Provides support to Dana-Farber Cancer Institute through investment management services. 0 true false false false false false false false true false true false false true false false true false false true false false false false false false false false true false false false false false false false true false false false false false true true false false false true 0 0 0 true true false false false false false false false false false X 4 1 true false false false false false false true true false false true true true true true true false false false MA X STEVEN CONNOLLY 6176323000 C/O DFCI 450 BROOKLINE BP418 BOSTON MA 02215 X Joshua Bekenstein 2.0 X X 0 0 0 Edward J Benz Jr MD 2.0 X X 0 1031510 214280 Richard K Lubin 2.0 X X 0 0 0 Stephen B Kay 2.0 X 0 0 0 Dorothy E Puhy 2.0 X 0 559483 37606 Richard S Boskey Esq 2.0 X 0 482576 52912 Kathleen Harkey 2.0 X 0 69442 5425 0 2143011 310223 0 false true false Baupost Value Partners IV LP 10 Saint James Avenue Suite 1700 BOSTON MA 02116 INVESTMENT Advisory 1117043 Cambridge Associates 100 Summer St 13 BOSTON MA 02110 Consulting Fees 375016 Silchester International Investors 780 Third Ave 42ND FL NEW YORK NY 10017 INVESTMENT Advisory 177243 BNY Mellon Bank 1 Boston Place BOSTON MA 02110 Custodian Fees 122612 Southeastern Asset Management 6410 Poplar Suite 900 MEMPHIS TN 38119 INVESTMENT Advisory 114976 11 0 0 3739583 -82559 3822142 0 0 514524093 478026683 36497410 36497410 36497410 0 0 0 0 40236993 -82559 40319552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2915190 2915190 0 0 0 0 0 0 0 0 0 0 0 0 0 2915190 0 2915190 0 28665737 22445119 102943978 93280651 414375561 456116647 545985276 571842417 545985276 571842417 545985276 571842417 X 0 0 0 0 0 0 0 0 545985276 571842417 X 37321803 -37321803 X false true true X false X X X X false false false DANA-FARBER CANCER INSTITUTE INC 042263040 03 true 0 1 0 179577000 9098000 8614000 0 0 10047000 187242000 158022000 7951000 18605000 0 0 5001000 179577000 200409000 4304000 -9423000 0 27334000 9934000 158022000 0.76790 0.23210 false false false COMINGLED FUNDS 137934901 F HEDGE FUNDS 206626547 F PRIV EQUITY & VENTURE CAP FUND 97435549 F REAL ESTATE FUNDS 14119650 F 456116647 0 HELD AS AGENT FOR DFCI 571842417 571842417 Part V, Line 4 - Intended Uses of Endowment Fund Schedule D, Part V, Question 4 As described in detail in the Audited Financial Statements, Dana-Farber Cancer Institute and its affiliates have endowments consisting of numerous individual funds established for a variety of purposes. These endowments consist solely of donor-restricted endowment funds. As required by Generally Accepted Accounting Principles, net assets associated with endowment funds are classified and reported based on the existence or absence of donor-imposed restrictions. All uses of the organization's endowment funds are directly related to Dana-Farber Cancer Institute and its affiliates' exempt mission and purposes. Dana-Farber Cancer Insitute receives contributions to the organization's endowment funds and transfers these amounts to be held in Dana-Farber, Inc. As of September 30, 2011, Dana-Faber, Inc. held $187,242,000 of endowments. Central America and the Caribbean 0 0 Investments 9851272 0 0 0 0 9851272 9851272 true false false false true false false true false false false false false false false Edward J Benz Jr MD 0 772250 0 121387 0 137873 0 167400 0 46880 0 1245790 0 0 Dorothy E Puhy 0 473160 0 38148 0 48175 0 0 0 37606 0 597089 0 0 Richard S Boskey Esq 0 415017 0 34267 0 33292 0 0 0 52912 0 535488 0 0 Schedule J, Part I Line 4b The following individuals participate in DFCI's 457(f) plan; taxable amounts are included in reportable compensation in Schedule J, Part II, Column (B)(iii): Name: Benz, Edward J. JR., MD 45,768.82 Boskey, Richard S., ESQ 14,591.86 Puhy, Dorothy 19,464.51 Berkshire Partners LLC See Part V 1662727 See Part V false Bain Capital See Part V 380000 See Part V false Part IV - Business Transactions DFI holds interests in alternative investments managed by Berkshire Partners LLC. Richard Lubin owns >5% of Berkshire Partners LLC.* DFI holds interests in alternative investments managed by Bain Capital. Joshua Bekenstein is a partner of Bain Capital and benefits financially from being a partner.* *All transactions are in the ordinary course of business and in compliance with the organaization's conflict of interest policy. Part IX, Line 2B Dana-Farber, Inc. is included in the consolidated Audited Financial Statements of Dana-Farber Cancer Institute, Inc. Form 990, Part VI, Question 2 Business & Family Relationships Business Relationship: Richard Lubin and Stephen Kay Form 990, Part VI, Line 11 Process used to review the Form 990 The Form 990 is prepared by the Tax Department and independently reviewed by Ernst & Young LLP for technical tax issues. After the Tax Department and Ernst & Young finalize the returns, The Chief Financial Officer of the Organization meets with the Tax Department to review the entire tax return in detail. If any changes need to be made, the Tax Department will make the changes in accordance with the CFO. After the CFO approves the return, certain sections are taken to Board Committees for a more detailed analysis. For example, the Board Compensation Committee reviews all information related to compensation in Part VII and Schedule J. Once the return has been through the committees who review certain sections, the tax return is presented to the Audit Committee for review and approval. After the audit committee approves the tax return, an electronic message is sent to all Board members with a secured link to the tax return. The Board has the opportunity to review the return and if any issues arise, they can bring them to the appropriate executive management individuals. The return is only filed after each of the steps in the review process is complete. Form 990, Part VI, Line 12c Monitoring & Enforcement of Conflict of Interest Policy The Office of General Counsel, the Assistant Secretary of the Board, and the Tax Department drafts a Conflict of Interest Disclosure Questionnaire each year and has all trustees, officers, and key employees fill out a questionnaire in regards to their personal situation and personal and business relationships. The Assistant Secretary compiles the list of Disclosures and gathers financial data from the Accounts Payable and Payroll Department for all organizations, employees, independent contractors, and other miscellaneous transactions which were disclosed by all individuals. Once all of this information is complied, the Office of General Counsel and the Tax Department goes through each transaction and disclosure to determine what needs to be disclosed on the tax return. The Tax Department and the Office of General Counsel also discusses if there are any other known transactions that have not been disclosed. If there are any questions regarding such situation, the Office of General Counsel and the Assistant Secretary will discuss the questions with the individual trustees involved. In addition the process described above, the governance committee of the board of directors annually reviews the conflict of interest disclosures and they address any issues that may arise. The governance committee is also responsible to bring any major issues related to the conflict of interest policy to the executive committee and the entire Board if deemed necessary. Per DFCI and Affiliate's conflict of interest policy, in order to avoid a conflict of interest or an appearance of a conflict of interest: 1. A Trustee should not participate in a vote on a transaction in which the Trustee or family member has a financial interest and should disclose any potential conflict before DFI acts on the transaction. 2. A Trustee, a member of his or her family, or an entity with which one or more of them has a material interest, may not do business with DFI unless expressly authorized by DFI after full disclosure. 3. A Trustee should fully disclose his or her association (including employment, consulting, or membership on a governing board by the Trustee or a family member) with an entity that competes with or has interests conflicting with those of DFI and should refrain from participating in any vote of other the organization if the vote affects DFI. Part VI, Question 19 Governing Documents We currently provide the governing documents upon request. We are reviewing our internal procedures to determine the best process to make our Governing Documents widely available. Conflict of Interest Policy DFI's Conflict of Interest Policy can be found within Dana-Farber Cancer Institute, Inc. & its Affiliates Code of Conduct, which is available on its website. Financial Statements We currently provide the audited financial statements upon request. We are reviewing our internal procedures to determine the best process to make our audited financial statements widely available. Part VII Individuals who receive compensation from related organizations work a total of 50 hours between DFI and the related organization. Part XII Line 5 Other Changes in net assets include: Net unrealized loss on investments ($14,583,893) Transfer of net assets to DFCI $(22,737,910) HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Edward J. Benz, Jr. MD TITLE:President, CEO, Trustee HOURS:50 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Dorothy E. Puhy TITLE:Assistant Treasurer HOURS:50 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Richard S. Boskey, Esq TITLE:Assistant Secretary HOURS:50 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Kathleen Harkey TITLE:Assistant Secretary HOURS:40 Dana-Farber Cancer Institute Inc 450 Brookline Avenue BP372 Boston MA 02215 042260340 Cancer Care MA 501(c)(3) 7 NA Dana-Farber Trust Inc 450 Brookline Ave BP372 Boston MA 02215 300195757 Rec. R/E Gift MA 501(c)(3) 11a DFCI FRIENDS OF DANA-FARBER CANCER INSTITUTE 450 BROOKLIKE ROAD BP418 BOSTON MA 02215 371613621 FUNDRAISING MA 501(C)(3) 11A, TYPE 1 DFCI false true false false false false false false false false false false false false false false true true Dana-Farber Cancer Institute Inc Q 218070595 Dana-Farber Cancer Institute Inc R 58146981 Dana-Farber Cancer Institute Inc b 22737910